The government has proposed extending the compliance deadline for revised Schedule M norms for pharmaceutical manufacturing.

With over 12 years in the pharmaceutical industry, Fayazoddin Mohamad excels in regulatory compliance and pharmacy management ...

Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "CMO in Pharmaceutical Industry ... clinical trial compliance. Supply chain issues continue to challenge CMOs, requiring quality management systems ...

Let's look at the transformative impact of AI and ML on financial risk management, their potential and the challenges that ...

Research projects that generative AI could boost the pharma and medical-product industries' annual revenues by up to $110 ...

As the pharmaceutical industry ... pose potential problems for companies in the industry. This makes the need for effective security and risk management ever more important – and an intelligence ...

Nearly half of India's 10,000 drug manufacturing units might not meet the 2025 deadline for upgrading to revised Schedule M ...

Impurities in pharmaceuticals are a major concern for drug manufacturers. This article will discuss the importance of ...

Companies can implement appropriate measures to prevent the misuse of technology, protect the integrity of their operations ...